EA
Publicaties op Oncologisch.com
Pharmacodynamics of Camizestrant Behandeling in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal...
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positi...
Serplulimab plus chemotherapie versus placebo bij uitgebreid SCLC: ASTRUM-005 fase III